SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027476
Filing Date
2018-11-06
Accepted
2018-11-06 16:42:49
Documents
46
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atrs-10q_20180930.htm 10-Q 1272687
2 EX-10.1 EMPLOYMENT AGREEMENT JAMES P TURSI atrs-ex101_12.htm EX-10.1 224686
3 EX-31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER atrs-ex311_8.htm EX-31.1 15552
4 EX-31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER atrs-ex312_6.htm EX-31.2 15814
5 EX-32.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER atrs-ex321_7.htm EX-32.1 6448
6 EX-32.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER atrs-ex322_9.htm EX-32.2 6459
  Complete submission text file 0001564590-18-027476.txt   4633756

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT atrs-20180930.xml EX-101.INS 953794
8 XBRL TAXONOMY EXTENSION SCHEMA atrs-20180930.xsd EX-101.SCH 31945
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atrs-20180930_cal.xml EX-101.CAL 35002
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atrs-20180930_def.xml EX-101.DEF 90950
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE atrs-20180930_lab.xml EX-101.LAB 252521
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atrs-20180930_pre.xml EX-101.PRE 186338
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32302 | Film No.: 181163564
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10